News Releases

Tuesday, March 11, 2014

Isakson Commends Administration's Decision to Withdraw Changes to Medicare Prescription Drug Program

Urges Administration to Also Re-think Devastating Cuts to Medicare Advantage Program

WASHINGTON – Today, U.S. Senator Johnny Isakson, R-Ga., issued the following statement regarding the Obama administration’s decision to withdraw proposed changes to the Medicare prescription drug program.

“I am pleased the administration has agreed to withdraw proposed changes to Medicare Part D that would have undermined the continued success of the Medicare prescription drug program and forced many Georgia seniors to lose their current drug coverage.  It is my hope the administration will similarly acknowledge the damage caused by Obamacare’s devastating cuts to the Medicare Advantage program and work with Congress to protect access to care and benefits for millions of seniors enrolled in these popular plans.”


In January, the Centers for Medicare and Medicaid Services (CMS) issued a 700-page proposed regulation that would significantly alter the Medicare Part D prescription drug program, which currently has a nearly 90 percent approval rating among beneficiaries.

Concerned with the adverse impact the proposed regulations would have on seniors enrolled in the successful prescription drug program, Isakson joined 19 Senate Finance Committee members, led by Chairman Wyden and Ranking Member Hatch, in sending a letter to CMS Administrator Marilyn Tavenner last month to urge the agency to reconsider proposed changes to the Medicare Part D prescription drug program.

Today, CMS announced it would shelve most of the proposed changes to the Part D program, including its proposed changes to protected drug classes, limitations on the number of plan choices available to seniors, and language on government interference in Part D.